| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 1e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.32 | 3e-09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 7e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |